Therapeutic antibodies

Results: 49



#Item
11Immunological Engineering Immunological Engineering represents a key strategy for dissecting and manipulating molecular processes and for development of proteins for diagnostics and therapeutic intervention. Our research

Immunological Engineering Immunological Engineering represents a key strategy for dissecting and manipulating molecular processes and for development of proteins for diagnostics and therapeutic intervention. Our research

Add to Reading List

Source URL: eng.au.dk

Language: English - Date: 2015-02-02 10:36:26
12Microsoft Word - GL-Immunogenicity assessment of therapeutic proteins

Microsoft Word - GL-Immunogenicity assessment of therapeutic proteins

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 04:57:48
13CALYPSO BIOTECH SA One line pitch: We develop therapeutic antibodies for severe gastrointestinal diseases Market Analysis: CALYprogram: IBD is a large market with important competition, but with good opportunities

CALYPSO BIOTECH SA One line pitch: We develop therapeutic antibodies for severe gastrointestinal diseases Market Analysis: CALYprogram: IBD is a large market with important competition, but with good opportunities

Add to Reading List

Source URL: www.biovision.org

Language: English - Date: 2015-03-26 10:58:27
14R&D BioProducts and American Peptide Company Partner to Develop Novel TRAF-6 Peptide Peptide offers significant therapeutic potential to researchers investigating ubiquitin-related neurodegenerative disorders (Greeley, C

R&D BioProducts and American Peptide Company Partner to Develop Novel TRAF-6 Peptide Peptide offers significant therapeutic potential to researchers investigating ubiquitin-related neurodegenerative disorders (Greeley, C

Add to Reading List

Source URL: www.americanpeptide.com

Language: English - Date: 2008-05-15 12:25:20
15Engineering Next-Generation Therapeutic Proteins: Trends and Markets toExecutive Summary Executive Summary

Engineering Next-Generation Therapeutic Proteins: Trends and Markets toExecutive Summary Executive Summary

Add to Reading List

Source URL: www.insightpharmareports.com

Language: English - Date: 2011-08-03 14:46:23
16COMMENTARY  Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes Is It a Solution? Lucienne Chatenoud

COMMENTARY Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes Is It a Solution? Lucienne Chatenoud

Add to Reading List

Source URL: diabetes.diabetesjournals.org

Language: English
17Therapeutic Antibody Drugs Being Designed for Self-Administration as Developers Seek Competitive Advantage Date: [removed]:17 PM CET Category: Health & Medicine Press release from: Greystone Research Associates

Therapeutic Antibody Drugs Being Designed for Self-Administration as Developers Seek Competitive Advantage Date: [removed]:17 PM CET Category: Health & Medicine Press release from: Greystone Research Associates

Add to Reading List

Source URL: www.openpr.com

Language: English
18Selexis SA to Partner and Exhibit at BIO 2013 Selexis to Meet with Companies Interested in Protein Drug Discovery, Cell Line Development and Lead Identification for Therapeutic Drug Development and Manufacturing. Geneva,

Selexis SA to Partner and Exhibit at BIO 2013 Selexis to Meet with Companies Interested in Protein Drug Discovery, Cell Line Development and Lead Identification for Therapeutic Drug Development and Manufacturing. Geneva,

Add to Reading List

Source URL: www.prweb.com

Language: English - Date: 2013-04-10 08:01:14
19Toxicologist, Therapeutic Antibody Development Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibod

Toxicologist, Therapeutic Antibody Development Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibod

Add to Reading List

Source URL: www.zymeworks.com

Language: English - Date: 2015-01-09 00:39:48
20Director, Therapeutic Antibody Discovery Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody drug

Director, Therapeutic Antibody Discovery Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody drug

Add to Reading List

Source URL: www.zymeworks.com

Language: English - Date: 2014-12-19 13:10:21